Philipp K. Haber

Also affiliated with Charité - Universitätsmedizin Berlin, Icahn School of Medicine at Mount Sinai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “CXCR2 inhibition enables NASH-HCC immunotherapy”.

CXCR2 inhibition enables NASH-HCC immunotherapy

Gut(2022)10.1136/gutjnl-2021-326259

N/A

4.8DataRank · unranked

230 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

Hepatology(2021)10.1002/hep.32023

N/A

0DataRank · unranked

164 citations

Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber +15 more

Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

Gut(2021)10.1136/gutjnl-2021-325036

N/A

0DataRank · unranked

63 citations

Teresa García‐Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig +27 more

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications

Gut(2022)10.1136/gutjnl-2021-326514

N/A

0DataRank · unranked

143 citations

Benjamin Kepecs, Miguel Torres‐Martín, Emily R. Bramel, Philipp K. Haber, Elliot Merritt +20 more

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0632

N/A

0DataRank · unranked

15 citations

Marc Puigvehí, Miguel Torres‐Martín, Huan Wang, Miho MAEDA, Philipp K. Haber +25 more

CXCR2 inhibition enables NASH-HCC immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.24.481779

N/A

0DataRank · unranked

3 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0335

N/A

0DataRank · unranked

15 citations

Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute +24 more

Unannotated small RNA clusters in circulating extracellular vesicles detect early stage liver cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.29.066183

N/A

0DataRank · unranked

3 citations

Teresa Garcia-Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig +27 more

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.12.016

N/A

0DataRank · unranked

44 citations

Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol +36 more